Orion Pharma (DHA:ORIONPHARM) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 02, 2026)


DHA:ORIONPHARM Orion Pharma Ltd DHA:ORIONPHARM
69 GF Score
Price BDT28.60
GF Value BDT20.31
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Orion Pharma Float Percentage Of Total Shares Outstanding?

Orion Pharma DHA:ORIONPHARM +0.35% 69 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 02, 2026. GuruFocus rates DHA:ORIONPHARM with a GF Score™ of 69/100 and a GF Value™ of BDT20.31 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Orion Pharma's float shares is 0.00 Mil. Orion Pharma's total shares outstanding is 234.00 Mil. Orion Pharma's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Orion Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Orion Pharma's Institutional Ownership is 0.11%.

DHA:ORIONPHARM
69GF Score
Orion Pharma Ltd DHA:ORIONPHARM
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orion Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Orion Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/234.00
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Orion Pharma (DHA:ORIONPHARM) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Orion Pharma and its competitors.
Is Orion Pharma's Float Percentage Of Total Shares Outstanding too high?
Orion Pharma's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Orion Pharma has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Orion Pharma's Float Percentage Of Total Shares Outstanding compare to CEG and VST?
Orion Pharma's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Utilities - Independent Power Producers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for an Utilities - Independent Power Producers company?
A good Float Percentage Of Total Shares Outstanding depends on the Utilities - Independent Power Producers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Orion Pharma and its competitors. Orion Pharma's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Pharma stock overvalued right now?
Based on GuruFocus' analysis, Orion Pharma (DHA:ORIONPHARM) is currently considered Significantly Overvalued. The stock's GF Value™ is BDT20.31, compared to a current price of BDT28.60 — trading 40.8% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Orion Pharma's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Orion Pharma (DHA:ORIONPHARM), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Orion Pharma (DHA:ORIONPHARM) Overvalued in 2026?

Based on GuruFocus' analysis, Orion Pharma stock appears to be overvalued. The current stock price of BDT28.60 is trading 40.8% above its estimated GF Value™ of BDT20.31. GuruFocus considers Orion Pharma to be Significantly Overvalued.

Key valuation signals for DHA:ORIONPHARM:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: BDT20.31 vs. price of BDT28.60 (40.8% above fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the DHA:ORIONPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Orion Pharma Business Description

Address 153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the creation and discovery, development, manufacturing, and marketing of pharmaceutical products, including vaccines and health-related consumer products. The company produces diversified dosage forms such as tablets, capsules, syrups, solutions, suspensions, powder for suspensions, creams, ointments, and injections under therapeutic categories including cardiovascular, antiulcerant, antiasthmatic, antihistamine, NSAIDs, antibiotic, antifungal, laxatives, anticancer, vitamins, and minerals. In addition, the company is involved in power generation activities and generates maximum revenue from pharmaceutical activities. The group principally carries out its business operations and markets its products in Bangladesh.
69GF Score

Get the complete analysis for DHA:ORIONPHARM

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT28.60
Price
BDT20.31
GF Value